CN100430088C - Chinese medicinal composition for treating hyperplasia of mammary glands and hysteromyoma - Google Patents

Chinese medicinal composition for treating hyperplasia of mammary glands and hysteromyoma Download PDF

Info

Publication number
CN100430088C
CN100430088C CNB2006100165122A CN200610016512A CN100430088C CN 100430088 C CN100430088 C CN 100430088C CN B2006100165122 A CNB2006100165122 A CN B2006100165122A CN 200610016512 A CN200610016512 A CN 200610016512A CN 100430088 C CN100430088 C CN 100430088C
Authority
CN
China
Prior art keywords
radix
hysteromyoma
processed
vinegar
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100165122A
Other languages
Chinese (zh)
Other versions
CN1840148A (en
Inventor
宋立学
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100165122A priority Critical patent/CN100430088C/en
Publication of CN1840148A publication Critical patent/CN1840148A/en
Application granted granted Critical
Publication of CN100430088C publication Critical patent/CN100430088C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to a Chinese medicinal compound for treating hyperplasia of mammary glands and hysteromyoma, which belongs to the technical field of Chinese medicinal compounds and is prepared from the following raw medicinal materials: 6% to 9% vinegar prepared Radix Bupleuri, 5% to 7% angelica 5% to 7% Curcuma aromatica, 6% to 9% Radix Paeoniae Alba, 5% to 7% of prepared turtle shell, 5% to 7% of pangolin scale, 7% to 12% of oyster shell, 5% to 9% of vinegar prepared Yuanhu, 5% to 9% of danshen root, 7% to 11% of Atractylodes macrocephala, 3% to 4% of earthworm, 3% to 4% of pericarpium citri reticulatae viriole, 6% to 9% of Glycyrrhiza uralensis and 10% to 16% of cornu cervi degelatinatum. With the components compatible with each other, the present invention has the functions of nourishing Qi and blood, promoting blood circulation and dredging stasis, promoting Qi and removing stagnation, punching channels and smoothing Qi and blood circulation without specific consumption of blood and promoting blood generation, and can be used for separately treating hyperplasia of mammary glands or hysteromyoma or for treating both of hyperplasia of mammary glands and hysteromyoma and for integrative regulation; the present invention has therapy and health care effects on mammary dysplasia and mammary shape change.

Description

A kind of Chinese medicine composition for the treatment of cyclomastopathy, hysteromyoma
Technical field
The invention belongs to the Chinese medicine composition technical field, relate to a kind of Chinese medicine composition for the treatment of cyclomastopathy, hysteromyoma.
Technical background
Cyclomastopathy, hysteromyoma are the gynecological clinic commonly encountered diseases, and along with the raising of people's living standard and the factors such as variation of living environment, the sickness rate of cyclomastopathy, hysteromyoma is ascendant trend year by year, become the modal benign tumor of women.Relevant statistics shows: the women is about more than 30 years old suffers from cyclomastopathy, uterine fibroid disease more than 20%, 85% above patient has and suffers from cyclomastopathy and hysteromyoma in various degree simultaneously.How cyclomastopathy, uterine fibroid disease exist simultaneously, are in close relations because of itself and liver spleen, uterus, and breast also belongs to Liver Channel.Liver is that dirty, main the dredging of blood rushed down, and has conditioning liver, spleen, stomach to dash the function of appointing, and is the crux that cyclomastopathy and hysteromyoma take place and develop so the physiological and pathological of liver, spleen, uterus changes.Stagnation of liver-QI with deficiency of the spleen is this, many, the incoordination between the liver and spleen smooth of ill cause, depression of liver-QI, not normal, the hematogenous blockage of catharsis by women's feelings will, or puerperal in menstrual period, the heresy of vessels of the uterus inanition, wind and cold is taken advantage of a weak point in opponent's defence and is invaded, daily life is careless in addition, so that blood stasis due to qi deficiency, the stasis of blood stagnate among the born of the same parents, and transverse invasion of hyperactive liver-QI is violated spleen, tie in breast, or cause in phlegm retention water-damp not being transformed and the blood stasis and stop, tie in uterus mutually and form muscular tumor.
Cyclomastopathy, hysteromyoma often occur distending pain of the breast, mood agitation, menoxenia, metrorrhagia, abdominal mass, waist abdomen weigh down expand, leucorrhea abnormal, infertile and symptoms such as miscarriage, anemia and hypertension, all produce serious influence for patient's work and study, life and human communication, obstinate, also can cause canceration, serious harm women's physical and mental health.
Now treat cyclomastopathy clinically, hysteromyoma adopts hormonotherapy, operative therapy more.
Hormone therapy can cause the disorder of hormonal system, produces manlikely, also influences side effect such as immune function, relapse rate height after the drug withdrawal simultaneously.Operative treatment then must be done hysterectomy or mammectomy, brings great injury for the female pathology psychological aspects.The possibility that part hysterectomy, the cervix uteri stump of leaving over have generation cancer (tumor) to become in the future; Whole hysterectomys, it is bigger to perform the operation, and operates near the unskilled internal organs that easily injure, and also can cause other complication.Simultaneously, excision breast, uterus can make women's endocrine seriously lack of proper care again, cause climacteric to reach physiological changies such as aging in advance.
More used clinically now Chinese patent medicines are not obtained gratifying effect as " rhubarb horsetail ball ", " RUPIXIAO ", " detumescence sheet " etc. on curative effect.Their common treatment characteristics are that specific aim, selectivity are strong, can only play therapeutical effect to certain cause of disease, disease; In treatment many with reconciliation, removing blood stasis, stimulate the menstrual flow, be dissipated as the master, and some medicine efficacy of a drug is pretty violent, and the fraud of " blood is attacked in blood stasis dispelling " is all arranged.And the ill most body void of women, companion menoxenia, how probably to feel bad and control, so be difficult to produce effects.
Summary of the invention
The present invention is according to " breast with uterus the exterior and the interior " mutually, " the different sick homology of cyclomastopathy and hysteromyoma ", with " all kinds of diseases and ailments are from void; all kinds of diseases and ailments are from the stasis of blood " theory, get to the bottom of sb.'s illness, distinguish its disease reason, adopt the full side's compatibility of Chinese herbal medicine, with nourishing blood to restore normal menstruation, dispersing the stagnated live-QI to relieve the stagnation of QI, hard masses softening and resolving, the clearing away phlegm dehumidifying, set upright QI invigorating, disappear to mend and be combined into this, purpose provides a kind of treatment cyclomastopathy, the Chinese medicine composition of hysteromyoma, make blood stasis dispelling and just do not hinder, eliminating mass and do not forget treating blood disorders, treating both the principal and secondary aspects of a disease, many unicity of prior art Chinese patent medicine and unilateral selective therapy have been solved, the efficacy of a drug is pretty violent, and how empty women's prolonged illness QI and blood is, probably difficult drawback of bearing, bring injury for female pathology psychology with operative treatment hysterectomy or mastectomy, and the problem of hormonotherapy toxic and side effects.
The present invention is made by following raw material medicines in percentage by weight: Radix Bupleuri (processed with vinegar) 6%~9%; Radix Angelicae Sinensis 5%~7%; Radix Curcumae 5%~7%; The Radix Paeoniae Alba 6%~9%; Carapax Trionycis (processed) 5%~7%; Squama Manis 5%~7%; Concha Ostreae 7%~12%; Vinegar system Rhizoma Corydalis 5%~9%; Radix Salviae Miltiorrhizae 5%~9%; The Rhizoma Atractylodis Macrocephalae 7%~11%; LUMBRICUS 3%~4%; Pericarpium Citri Reticulatae Viride 3%~4%; Radix Glycyrrhizae 6%~9%; Cornu Cervi Degelatinatum 10%~16%.
Radix Angelicae Sinensis: sweet, hot, warm, return liver, the heart, spleen channel, have enrich blood, invigorate blood circulation, the function of regulating menstruation, pain relieving, intestine moistening; The Radix Paeoniae Alba: bitter, acid, be slightly cold, return liver, spleen channel, have the function of easing the affected liver to relieve pain, nourishing blood for regulating menstruation, astringing YIN to stop sweating, suppressing liver-YANG; The Rhizoma Atractylodis Macrocephalae: bitter, sweet, warm, return spleen, stomach warp, have invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive function; Radix Salviae Miltiorrhizae: bitter, be slightly cold, GUIXIN, Liver Channel have stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, a function of the relieving restlessness that clears away heart-fire.Radix Angelicae Sinensis, the Radix Paeoniae Alba, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae 4 flavors are monarch drug altogether, strengthening vital QI to eliminate pathogenic factors, benefiting vital QI and blood.
Radix Bupleuri: bitter, hot, be slightly cold, return liver, gallbladder, spleen, stomach, tri-jiao channel, have to evacuate and bring down a fever dispersing the stagnated live-QI to relieve the stagnation of QI, the function of ascending up spleen-Qi and Yang; Radix Curcumae: hot, bitter, cold, return liver, the heart, lung meridian, have regulating qi to disperse stagnation, heart fire-clearing upset-relieving, the function of promoting the function of the gallbladder to alleviate jaundice; Rhizoma Corydalis: hot, bitter, warm, return liver, spleen channel, have invigorate blood circulation, promoting the circulation of QI, analgesic function; Pericarpium Citri Reticulatae Viride: bitter, hot, warm, return liver, gallbladder, stomach warp, have soothing the liver dispelling the stagnated QI, the stagnant function of removing food stagnancyization; Cornu Cervi Degelatinatum: salty, warm, return liver, kidney channel, have the kidney warming sun, bone and muscle strengthening, promoting the circulation of blood repercussive function; Radix Bupleuri, Radix Curcumae, Rhizoma Corydalis, Pericarpium Citri Reticulatae Viride, Cornu Cervi Degelatinatum are ministerial drug altogether, depressed liver-energy dispersing and QI regulating, regulating thoroughfare and controlling vessel, channel warming and blood nourishing pain relieving.
Carapax Trionycis: salty, be slightly cold, return liver, kidney channel, have nourishing YIN for suppressing the hyperactive YANG, hard masses softening and resolving, bring down a fever and remove the function of steaming; Squama Manis: salty, be slightly cold, return liver, stomach warp, have the function of the stimulating milk secretion of stimulating the menstrual flow, detumescence and apocenosis, expel wind to dredge collateral; Concha Ostreae: salty, be slightly cold, return liver, gallbladder, kidney channel, have tranquillization with heavy prescription, YANG hyperactivity suppressing nourishing YIN, hard masses softening and resolving, the astringent or styptic treatment for spontaneous sweating function of convergence; LUMBRICUS: salty, cold, return liver, spleen, urinary bladder channel; Carapax Trionycis, Squama Manis, Concha Ostreae, LUMBRICUS are adjuvant drug altogether, reduce phlegm stimulate the menstrual flow, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, detumescence disease;
Radix Glycyrrhizae: sweet, flat, GUIXIN, lung, spleen, stomach warp have the function of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription, be messenger drug, soothing the liverly reach strongly fragrant and do not forget to enrich blood, regulating the flow of QI to dissipate blood stasis is given birth to QI and blood, hard masses softening and resolving, clearing away phlegm dehumidifying and just do not hinder.
The full side's compatibility of the present invention is benefiting QI and nourishing blood both, and promoting the circulation of blood divides the stasis of blood to stagnate again, separates edema caused by disorder of QI pent-up again, dashes wantonly two arteries and veins QI and blood and leads to; Invigorate blood circulation and hematozemia not, blood stasis dispelling again can tissue regeneration promoting; Close and use it, make the stasis of blood row that degass, then all diseases can be healed.Both can treat cyclomastopathy, hysteromyoma separately, can control comprehensively regulating simultaneously again; To breast dysplasia, breast is flat, breast is lax, suckling rear udder attachment body changes, and treatment and health-care effect are also arranged.Clinical use 7211 examples, wherein simple hysteromyoma person 1975 people account for 27.5%; Simple cyclomastopathy person 2603 people account for 36%, and cyclomastopathy merges hysteromyoma person 2633 people, accounts for 36.5%; Cyclomastopathy lump maximum 13 * 10cm, minimum 2 * 3cm, hysteromyoma maximum 6.9 * 8.3cm, minimum 1.0 * 2.6cm, the course of treatment is the longest 6 months, and is the shortest 20 days, average 120 days.Therapeutic outcome: cure 5747 people, account for 79.7%, produce effects 793 people account for 11%, and effective 671 people account for 9.3%, total effective rate 100%.
The specific embodiment
Embodiment 1
The present invention is made by the following materials by weight percentage medicine:
Radix Bupleuri (processed with vinegar) 7.85%; Radix Angelicae Sinensis 6.13%; Radix Curcumae 6.13%; The Radix Paeoniae Alba 7.85%; Carapax Trionycis (processed) 6.13%; Squama Manis 6.50%; Concha Ostreae 9.82%; Vinegar system Rhizoma Corydalis 6.50%; Radix Salviae Miltiorrhizae 6.32%; The Rhizoma Atractylodis Macrocephalae 9.82% LUMBRICUS 3.25%; Pericarpium Citri Reticulatae Viride 3.25%; Radix Glycyrrhizae 7.36%; Cornu Cervi Degelatinatum 13.09%.
Embodiment 2
The present invention is made by the following materials by weight percentage medicine:
Radix Bupleuri (processed with vinegar) 7.00%; Radix Angelicae Sinensis 6.80%; Radix Curcumae 6.80%; The Radix Paeoniae Alba 6.90%; Carapax Trionycis (processed) 5.80%; Squama Manis 5.80%; Concha Ostreae 10.50%; Vinegar system Rhizoma Corydalis 7.50%; Radix Salviae Miltiorrhizae 6.80%; The Rhizoma Atractylodis Macrocephalae 8.80%; LUMBRICUS 3.75%; Pericarpium Citri Reticulatae Viride 3.75%; Radix Glycyrrhizae 7.80%; Cornu Cervi Degelatinatum 12.00%.
Embodiment 3
The present invention is made by the following materials by weight percentage medicine:
Radix Bupleuri (processed with vinegar) 8.85%; Radix Angelicae Sinensis 6.63%: Radix Curcumae 6.63%; The Radix Paeoniae Alba 8.85%; Carapax Trionycis (processed) 5.13%; Squama Manis 5.50%; Concha Ostreae 11.82%; Vinegar system Rhizoma Corydalis 7.50%; Radix Salviae Miltiorrhizae 7.32%; The Rhizoma Atractylodis Macrocephalae 7.32%; LUMBRICUS 3.25%; Pericarpium Citri Reticulatae Viride 3.85%; Radix Glycyrrhizae 6.76%; Cornu Cervi Degelatinatum 10.59%.
Embodiment 4
The present invention is made by the following materials by weight percentage medicine:
Radix Bupleuri (processed with vinegar) 6.30%; Radix Angelicae Sinensis 6.60%; Radix Curcumae 5.63%; The Radix Paeoniae Alba 6.85%; Carapax Trionycis (processed) 6.63%; Squama Manis 6.85%; Concha Ostreae 7.35%; Vinegar system Rhizoma Corydalis 5.5%; Radix Salviae Miltiorrhizae 5.82%; The Rhizoma Atractylodis Macrocephalae 10.82%; LUMBRICUS 3.85%; Pericarpium Citri Reticulatae Viride 3.55%; Radix Glycyrrhizae 8.36%; Cornu Cervi Degelatinatum 15.89%.
Preparation technology of the present invention is as follows:
Press embodiment 1,2,3 or 4 described percentage by weight weighting raw materials, prepare according to following method:
Carapax Trionycis (processed), Squama Manis, Concha Ostreae, vinegar system Rhizoma Corydalis, LUMBRICUS five tastes crude drug are ground into 120 orders~200 purpose fine powder mixings; Radix Bupleuri (processed with vinegar), Radix Angelicae Sinensis, Radix Curcumae, the Radix Paeoniae Alba, Radix Salviae Miltiorrhizae, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae Viride, Radix Glycyrrhizae, Cornu Cervi Degelatinatum nine flavor crude drug decoct with water secondary, 2 hours for the first time, 1 hour for the second time, filter, merging filtrate, be condensed into the thick paste shape, drying is ground into 120 orders~200 order fine powders, mix and grind with above-mentioned Carapax Trionycis (processed), Squama Manis, Concha Ostreae, vinegar system Rhizoma Corydalis, LUMBRICUS five tastes crude drug fine powder, mixing is made the medicine grain, every 0.45~0.5 gram.
Usage and dosage: oral, one time four to six.Three times on the one.

Claims (5)

1, a kind of Chinese medicine composition for the treatment of cyclomastopathy, hysteromyoma is characterized in that being made by following raw material medicines in percentage by weight: Radix Bupleuri (processed with vinegar) 6%~9%; Radix Angelicae Sinensis 5%~7%; Radix Curcumae 5%~7%; The Radix Paeoniae Alba 6%~9%; Carapax Trionycis (processed) 5%~7%; Squama Manis 5%~7%; Concha Ostreae 7%~12%; Vinegar system Rhizoma Corydalis 5%~9%; Radix Salviae Miltiorrhizae 5%~9%; The Rhizoma Atractylodis Macrocephalae 7%~11%; LUMBRICUS 3%~4%; Pericarpium Citri Reticulatae Viride 3%~4%; Radix Glycyrrhizae 6%~9%; Cornu Cervi Degelatinatum 1 0%~16%.
2, the Chinese medicine composition of treatment cyclomastopathy according to claim 1, hysteromyoma is characterized in that being made by following raw material medicines in percentage by weight: Radix Bupleuri (processed with vinegar) 7.85%; Radix Angelicae Sinensis 6.13%; Radix Curcumae 6.13%; The Radix Paeoniae Alba 7.85%; Carapax Trionycis (processed) 6.13%; Squama Manis 6.50%; Concha Ostreae 9.82%; Vinegar system Rhizoma Corydalis 6.50%; Radix Salviae Miltiorrhizae 6.32%; The Rhizoma Atractylodis Macrocephalae 9.82%; LUMBRICUS 3.25%; Pericarpium Citri Reticulatae Viride 3.25%; Radix Glycyrrhizae 7.36%; Cornu Cervi Degelatinatum 13.09%.
3, the Chinese medicine composition of treatment cyclomastopathy according to claim 1, hysteromyoma is characterized in that being made by following raw material medicines in percentage by weight: Radix Bupleuri (processed with vinegar) 7.00%; Radix Angelicae Sinensis 6.80%; Radix Curcumae 6.80%; The Radix Paeoniae Alba 6.90%; Carapax Trionycis (processed) 5.80%; Squama Manis 5.80%; Concha Ostreae 10.50%; Vinegar system Rhizoma Corydalis 7.50%; Radix Salviae Miltiorrhizae 6.80%; The Rhizoma Atractylodis Macrocephalae 8.80%; LUMBRICUS 3.75%; Pericarpium Citri Reticulatae Viride 3.75%; Radix Glycyrrhizae 7.80%; Cornu Cervi Degelatinatum 12.00%.
4, the Chinese medicine composition of treatment cyclomastopathy according to claim 1, hysteromyoma is characterized in that being made by following raw material medicines in percentage by weight: Radix Bupleuri (processed with vinegar) 8.85%; Radix Angelicae Sinensis 6.63%; Radix Curcumae 6.63%; The Radix Paeoniae Alba 8.85%; Carapax Trionycis (processed) 5.13%; Squama Manis 5.50%; Concha Ostreae 11.82%; Vinegar system Rhizoma Corydalis 7.50%; Radix Salviae Miltiorrhizae 7.32%; The Rhizoma Atractylodis Macrocephalae 7.32%; LUMBRICUS 3.25%; Pericarpium Citri Reticulatae Viride 3.85%; Radix Glycyrrhizae 6.76%; Cornu Cervi Degelatinatum 10.59%.
5, the Chinese medicine composition of treatment cyclomastopathy according to claim 1, hysteromyoma is characterized in that being made by following raw material medicines in percentage by weight: Radix Bupleuri (processed with vinegar) 6.30%; Radix Angelicae Sinensis 6.60%; Radix Curcumae 5.63%; The Radix Paeoniae Alba 6.85%; Carapax Trionycis (processed) 6.63%; Squama Manis 6.85%; Concha Ostreae 7.35%; Vinegar system Rhizoma Corydalis 5.5%; Radix Salviae Miltiorrhizae 5.82%; The Rhizoma Atractylodis Macrocephalae 10.82%; LUMBRICUS 3.85%; Pericarpium Citri Reticulatae Viride 3.55%; Radix Glycyrrhizae 8.36%; Cornu Cervi Degelatinatum 15.89%.
CNB2006100165122A 2006-01-11 2006-01-11 Chinese medicinal composition for treating hyperplasia of mammary glands and hysteromyoma Expired - Fee Related CN100430088C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100165122A CN100430088C (en) 2006-01-11 2006-01-11 Chinese medicinal composition for treating hyperplasia of mammary glands and hysteromyoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100165122A CN100430088C (en) 2006-01-11 2006-01-11 Chinese medicinal composition for treating hyperplasia of mammary glands and hysteromyoma

Publications (2)

Publication Number Publication Date
CN1840148A CN1840148A (en) 2006-10-04
CN100430088C true CN100430088C (en) 2008-11-05

Family

ID=37029452

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100165122A Expired - Fee Related CN100430088C (en) 2006-01-11 2006-01-11 Chinese medicinal composition for treating hyperplasia of mammary glands and hysteromyoma

Country Status (1)

Country Link
CN (1) CN100430088C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102648945A (en) * 2011-02-28 2012-08-29 刘树平 Chinese medicinal formula for treating hysteromyoma
CN102755602B (en) * 2012-08-15 2014-01-15 赵冲祥 Health care product for relieving hyperplasia of mammary glands
CN104758795A (en) * 2014-01-07 2015-07-08 黑龙江省传奇生物医药科技开发有限公司 Traditional Chinese medicine pills for treating lumps in breasts and preparation method
CN104971075A (en) * 2015-06-22 2015-10-14 启发坤 Method adopting compound traditional Chinese medicine to treat uterine fibroid and uterine cancer
CN110227135A (en) * 2019-06-17 2019-09-13 河南利联科技有限公司 A kind of Chinese medicine composition and preparation method thereof for treating the proliferation of mammary gland
CN111991537A (en) * 2020-09-24 2020-11-27 深圳市纯原上品生物科技有限公司 A Chinese medicinal composition for treating female hyperplasia of mammary glands and preventing canceration, and its preparation method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1318409A (en) * 2001-04-20 2001-10-24 于子民 Mastoproliferation treating capsule

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1318409A (en) * 2001-04-20 2001-10-24 于子民 Mastoproliferation treating capsule

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
乳腺增生病的中医药治疗研究. 秦元刚等.中原医刊,第32卷第24期. 2005
乳腺增生病的中医药治疗研究. 秦元刚等.中原医刊,第32卷第24期. 2005 *

Also Published As

Publication number Publication date
CN1840148A (en) 2006-10-04

Similar Documents

Publication Publication Date Title
CN100430088C (en) Chinese medicinal composition for treating hyperplasia of mammary glands and hysteromyoma
CN103349753A (en) Traditional Chinese medicine composition for treating kidney deficiency
CN105663607A (en) Traditional Chinese medicine composition as well as preparation method and application thereof
CN102357177B (en) Traditional Chinese medicine for curing climacteric metancholia
CN105664099A (en) Traditional Chinese medicine composition for warming and invigorating kidney yang and preparation method thereof
CN101966289A (en) Chinese medicinal composition for treating frigidity and preparation method thereof
CN104288631A (en) Medicine composition for treating colon cancer and preparation method thereof
CN104689096A (en) Depressive neurosis treating traditional Chinese medicine composition
CN103599404A (en) Traditional Chinese medicinal decoction for treating cervical spondylosis
CN102600335B (en) Traditional Chinese medicine for treating postpartum hypogalactia
CN115779064A (en) Astragalus root strengthening body resistance and preparation and application thereof
CN105126020A (en) Traditional Chinese medicine for treating puerperal galactorrhea with syndrome of liver depression transforming into fire
CN104645249A (en) Medicine for treating coronary heart disease and angina
CN103736003A (en) Medicament for treating mammary hyperplasia
CN104740142A (en) Traditional Chinese medicine for treating sciatica
CN100569270C (en) The medicine of treatment mastalgia
CN102940716A (en) Traditional Chinese medicine for treatment of uterine prolapse
CN103212044B (en) Traditional Chinese medicine composition for treating cardiovascular diseases
CN105267538A (en) Pilose antler paste for treatment of irregular menstruation and preparation method thereof
CN101259186B (en) Medicinal and edible dual-purpose powder for treating milk unsmooth and mammary swelling pain
CN104069463A (en) Traditional Chinese medicinal medicament for treating gynaecological metrorrhagia and metrostaxis
CN104042839A (en) Traditional Chinese medicine composition for treating tinea versicolor
CN108079073A (en) It is a kind of steep pedicure tremble with fear foot alleviate medicine Chinese medicine powder
CN102626506B (en) Traditional Chinese medicine for curing seroperitoneum
CN104758542A (en) Traditional Chinese medicine composition for treating uterine prolapse caused by deficiency of kidney qi

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee